The impact of Hepatitis C viral load determined short-course treatment vs fixed duration treatment on Hepatitis C cure for patients with mild genotype-1 Hepatitis C disease

Trial Profile

The impact of Hepatitis C viral load determined short-course treatment vs fixed duration treatment on Hepatitis C cure for patients with mild genotype-1 Hepatitis C disease

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs Ombitasvir/paritaprevir/ritonavir (Primary) ; Dasabuvir; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms STOPHCV-1
  • Most Recent Events

    • 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
    • 19 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top